Home > Financial Ratios > ONESOURCE SPECIALTY PHARMA

ONESOURCE SPECIALTY PHARMA
Core EBITDA Margin

    Back to All Ratios
ONESOURCE SPECIALTY PHARMA is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
AD     Remove this Ad

ONESOURCE SPECIALTY PHARMA Last 5 Year Core EBITDA Margin History

[Standalone]

Mar2025Mar2024Mar2023
   Core EBITDA Margin(%) 28.09-50.91-414.89

What is the latest Core EBITDA Margin ratio of ONESOURCE SPECIALTY PHARMA ?

The latest Core EBITDA Margin ratio of ONESOURCE SPECIALTY PHARMA is 28.09 based on Mar2025 Standalone results.
Year Core EBITDA Margin
Mar202528.09
Mar2024-50.91
Mar2023-414.89

How is Core EBITDA Margin of ONESOURCE SPECIALTY PHARMA Trending?

Years Core EBITDA Margin % Change
Mar2025 28.09
Positive
Mar2024 -50.91
Negative
Mar2023 -414.89 -

Other Financial Ratios of ONESOURCE SPECIALTY PHARMA


Compare Core EBITDA Margin ratio of peers of ONESOURCE SPECIALTY PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ONESOURCE SPECIALTY PHARMA ₹17,135.6 Cr 1.6% 22.7% -0.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹427,693.0 Cr -1.7% 4% 11.8% Stock Analytics
DIVIS LABORATORIES ₹161,270.0 Cr -4.7% -1.8% 10.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,281.0 Cr -3.7% 4.5% 42.9% Stock Analytics
DR REDDYS LABORATORIES ₹106,422.0 Cr -3% 0% 15.4% Stock Analytics
CIPLA ₹104,915.0 Cr -2.6% -2.3% -10.1% Stock Analytics


ONESOURCE SPECIALTY PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ONESOURCE SPECIALTY PHARMA

1.6%

22.7%

-0.2%

SENSEX

-2.7%

-10.4%

1.6%


You may also like the below Video Courses